Mediastinal nonseminomatous germ cell tumor (NSGCT) is a malignant extragonadal germ cell tumor arising primarily in the anterior mediastinum. It may consist of embryonal carcinoma, yolk sac tumor, choriocarcinoma, immature teratoma, or mixed components. It accounts for approximately 40% of all mediastinal germ cell tumors and follows a more aggressive course than seminoma. There is marked predominance in young men aged 15-35 (male:female ratio >10:1). Association with Klinefelter syndrome in 20% of cases has been described. Elevated AFP (alpha-fetoprotein) and/or beta-hCG are critical for diagnosis — while AFP is not elevated in seminoma, AFP elevation in NSGCT is diagnostic. On CT, it appears as a large (usually >10 cm), heterogeneous mass in the anterior mediastinum with necrosis and hemorrhage. Vascular invasion, pleural/pericardial effusion, and hematogenous metastasis (lung, liver, bone, brain) are common. Treatment involves cisplatin-based chemotherapy (BEP regimen) as first line; residual mass after chemotherapy is surgically resected. 5-year survival is approximately 40-60%.
Age Range
15-35
Peak Age
25
Gender
Male predominant
Prevalence
Rare
Mediastinal NSGCTs originate from primordial germ cells that have settled in the thymus or anterior mediastinum during embryonic development. During normal development, these cells migrate to the genital ridge; migration defects can cause them to remain in the mediastinum. These ectopic germ cells undergo malignant transformation and can develop different histological components: embryonal carcinoma (pluripotent — most undifferentiated), yolk sac tumor (secretes AFP — endodermal sinus histology), choriocarcinoma (secretes beta-hCG — trophoblastic differentiation), and immature teratoma. Heterogeneous imaging findings (necrosis, hemorrhage, cystic changes) reflect the biological properties of these different components: choriocarcinoma is prone to hemorrhage (rich vascularity and trophoblastic invasion), yolk sac components form solid enhancing areas, teratomatous areas may show cystic changes and calcification. NSGCTs are more aggressive than seminomas because they have higher capacity for rapid proliferation, early vascular invasion, and hematogenous metastasis. The extra X chromosome in Klinefelter syndrome (47,XXY) affects germ cell biology and increases mediastinal GCT risk.
A large, heterogeneous mass with necrosis and hemorrhage in the anterior mediastinum combined with serum AFP elevation in a 15-35 year old male is pathognomonic for mediastinal NSGCT. AFP elevation excludes seminoma.
On contrast-enhanced CT, large (usually >10 cm), markedly heterogeneous mass in the anterior mediastinum. Heterogeneous enhancement is seen in solid components; necrotic and cystic areas do not enhance. The enhancement pattern is irregular — thick septa, peripheral enhancement, and necrotic centers are typical. The mass usually fills the anterior mediastinum bilaterally and may show invasion into surrounding structures. Solid enhancing areas represent active tumor components (embryonal carcinoma, yolk sac).
Report Sentence
Large mass measuring __ cm in the anterior mediastinum with markedly heterogeneous enhancement containing necrosis and cystic areas; nonseminomatous germ cell tumor should be the leading consideration.
On non-contrast CT, high-density (50-80 HU) hemorrhagic areas may be detected within the mass. This finding particularly suggests choriocarcinoma component — choriocarcinoma is highly prone to hemorrhage due to trophoblastic vascular invasion. Hemorrhagic areas are irregularly distributed and may be extensive relative to tumor size. Additionally, calcification or bone density foci suggest teratomatous component.
Report Sentence
High-density hemorrhagic areas are observed within the mass on non-contrast images, suggesting choriocarcinoma component.
In the portal venous phase, invasion of major vessels such as SVC, brachiocephalic veins, or pulmonary arteries is evaluated. NSGCT shows an aggressive growth pattern and frequently encases or invades vascular structures. Filling defect in vessel lumen (tumor thrombus), vessel wall irregularity, or decrease in vessel caliber suggests invasion. SVC syndrome may accompany clinically. Vascular invasion is a critical factor determining resectability. Staging CT should include chest, abdomen, and pelvis — lung and liver metastases should be sought.
Report Sentence
The mass encases/invades the superior vena cava / brachiocephalic veins with filling defect in the lumen; vascular invasion is a significant finding affecting surgical resectability.
On T2-weighted images, the mass shows markedly heterogeneous mixed signal. Cystic/necrotic areas appear T2 hyperintense, solid components show intermediate signal, and hemorrhagic areas appear hypointense. This mixed signal pattern reflects the multiple histological components. T2 imaging is superior to CT in mapping different tumor components — particularly in differentiating teratomatous cystic areas, hemorrhagic foci, and solid tumor tissue.
Report Sentence
The mass demonstrates markedly heterogeneous mixed signal on T2-weighted images with coexisting cystic, solid, and hemorrhagic components; consistent with multiple histological components of nonseminomatous germ cell tumor.
On T1-weighted images, high signal (hyperintense) foci within the mass represent hemorrhage or proteinaceous content. Methemoglobin (subacute hemorrhage product) produces bright signal through T1 shortening effect. Hemorrhagic foci are irregularly distributed and more prominent in choriocarcinoma component. Fat-containing teratomatous areas also appear T1 hyperintense — differentiated by fat suppression sequences.
Report Sentence
Hyperintense foci within the mass on T1-weighted sequences are consistent with intralesional hemorrhage; suggesting choriocarcinoma component.
On DWI, solid tumor components show marked diffusion restriction (high DWI signal, low ADC). ADC values are low in highly cellular embryonal carcinoma and yolk sac components (<1.0 x 10^-3 mm2/s). Necrotic/cystic areas show high ADC. DWI is also critical in evaluating treatment response — ADC increase after chemotherapy indicates tumor necrosis.
Report Sentence
Marked diffusion restriction is observed in the solid components of the mass, consistent with high cellularity and active tumor tissue.
Heterogeneous high FDG uptake on PET-CT. Solid viable components show intense uptake (SUVmax >10), necrotic areas show no uptake. Post-treatment mature teratoma residue is FDG-negative — PET-CT is critical for metabolic assessment of residual mass. Whole-body PET-CT evaluates distant metastases (lung, liver, bone, brain) for staging.
Report Sentence
The mass shows heterogeneous high FDG uptake on PET-CT; differentiation between solid viable components and necrotic areas is achievable.
Criteria
Most undifferentiated germ cell tumor; pluripotent structure, AFP and beta-hCG may be mildly elevated
Distinct Features
Solid, aggressive-appearing mass on CT. Necrosis is common but hemorrhage less than choriocarcinoma. Marked diffusion restriction in solid components on MRI. Aggressive behavior: early metastasis and vascular invasion.
Criteria
AFP markedly elevated; Schiller-Duval bodies are histologically pathognomonic
Distinct Features
Solid dominant mass on CT with marked enhancement. AFP >1000 ng/mL is common. Good chemotherapy response — AFP monitoring critical for treatment monitoring.
Criteria
Beta-hCG markedly elevated; AFP normal or mildly elevated; trophoblastic differentiation
Distinct Features
Highly prone to hemorrhage — hyperdense hemorrhagic areas on CT, methemoglobin hyperintensity on MRI T1. Gynecomastia may occur in young men (hCG effect). Most aggressive subtype — early hematogenous metastasis. Worst prognosis.
Criteria
Two or more histological components combined; most common form of NSGCT
Distinct Features
Most heterogeneous appearance on CT/MRI — solid, cystic, hemorrhagic, and calcified areas coexisting. Both AFP and beta-hCG may be elevated. Prognosis depends on dominant component.
Distinguishing Feature
Seminoma is usually a more homogeneously enhancing mass; necrosis and hemorrhage are less prominent. AFP is NOT elevated in seminoma — AFP elevation excludes seminoma. Seminoma is more sensitive to chemo/radiotherapy.
Distinguishing Feature
Thymoma is usually well-circumscribed, homogeneous or mildly heterogeneous. Serum markers negative. Paraneoplastic syndromes suggest thymoma. Thymoma usually at 40-60 years, NSGCT at 15-35.
Distinguishing Feature
Mature teratoma is well-circumscribed, cystic-dominant; fat-fluid level and calcification pathognomonic. AFP and beta-hCG NORMAL in mature teratoma. NSGCT is heterogeneous, aggressive, markers elevated.
Distinguishing Feature
Hodgkin lymphoma forms homogeneous or mildly heterogeneous mass; AFP and beta-hCG negative. B symptoms suggest lymphoma. High FDG uptake present in both.
Urgency
urgentManagement
medicalBiopsy
NeededFollow-up
specialist-referralMediastinal NSGCT is an aggressive malignant tumor requiring urgent oncological evaluation. Serum AFP and beta-hCG must be obtained before biopsy. Cisplatin-based chemotherapy (BEP regimen) is first line; residual mass after chemotherapy is surgically resected. Testicular examination and US should exclude primary testicular tumor. Klinefelter screening with 47,XXY karyotype. Prognosis worse than seminoma — 5-year survival approximately 40-60%. AFP and beta-hCG are critical for treatment monitoring.
Mediastinal NSGCT is an aggressive tumor treated with chemotherapy (BEP) + surgery. AFP and β-hCG are used for treatment response monitoring. Prognosis is worse than seminoma. Association with Klinefelter syndrome has been reported.